Asthma Treatment Standard Set from CAYMAN CHEMICAL COMPANY

Search, find, compare suppliers for Asthma Treatment Standard Set products.

Edit 
Product NameAsthma Treatment Standard Set
DescriptionThe Cayman Asthma Treatment Standard Set contains three potent, selective Cysteinyl Leukotriene (CysLT) 1 receptor antagonists (10 mg each) currently used clinically for the treatment of asthma. Zafirlukast and Montelukast (sodium salt), sold under the trade names Accolate and Singulair, respectively, are used for the treatment of asthma as well as for the symptoms associated with allergic rhinitis.{14098,14099,14106} Pranlukast, sold under the trade name Ultair, was the first CysLT receptor antagonist marketed for the treatment of asthma.{14103,14104} In addition to these three CysLT1 receptor antagonists, the asthma pak also includes Zileuton, which is supplied free of charge. Zileuton is a reversible 5-LO inhibitor that was approved in 1997 for the prevention and treatment of asthma in the USA, but was withdrawn by Abbott Laboratories in 2003.{1367,13304}
Size1 ea
Concentrationn/a
Applicationsn/a
Other NamesCysLT1 receptors cysteinyl leukotrienes asthma allergy antagonists LTC4 LTD4 hypersensitivity oral peptidyl LTRA bronchoconstriction montelukast pranlukast zafirlukast zileuton 10006967 packs
Gene, Accession, CAS #n/a
Catalog #10008640-1EA
Price$76.00
Order / More InfoAsthma Treatment Standard Set from CAYMAN CHEMICAL COMPANY
Product Specific Referencesn/a
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640

Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com

http://www.caymanchem.com

Facebook

Twitter


Profile of CAYMAN CHEMICAL COMPANY

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.